BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6675681)

  • 21. Naturally occurring anti-band 3 antibodies have a unique affinity for C3.
    Lutz HU; Nater M; Stammler P
    Immunology; 1993 Oct; 80(2):191-6. PubMed ID: 8262548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocyte vesiculation: a self-protective mechanism?
    Willekens FL; Werre JM; Groenen-Döpp YA; Roerdinkholder-Stoelwinder B; de Pauw B; Bosman GJ
    Br J Haematol; 2008 May; 141(4):549-56. PubMed ID: 18419623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red cell aging: senescent cell antigen, band 3, and band 3 mutations associated with cellular dysfunction.
    Kay MM
    Prog Clin Biol Res; 1989; 319():199-217; discussion 218-23. PubMed ID: 2533686
    [No Abstract]   [Full Text] [Related]  

  • 24. A cell-age specific antigen on senescent human red blood cells.
    Lutz HU
    Acta Biol Med Ger; 1981; 40(4-5):393-400. PubMed ID: 7315088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding of a polyclonal antibody against human band 3 to in vitro aged erythrocytes.
    Klinger MH; Halbhuber KJ; Linss W; Feuerstein H; Gaczynska M
    Acta Histochem; 1990; 88(1):71-6. PubMed ID: 2113343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Band 3 in aging and neurological disease.
    Kay MM
    Ann N Y Acad Sci; 1991; 621():179-204. PubMed ID: 1859086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of membrane-bound IgG and desialysation in the interaction of monocytes with senescent erythrocytes.
    Ensinck A; Biondi CS; Marini A; García Borrás S; Racca LL; Cotorruelo CM; Racca AL
    Clin Exp Med; 2006 Oct; 6(3):138-42. PubMed ID: 17061064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of sialylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent erythrocytes in anti-band 3 autoantibody binding.
    Ando K; Kikugawa K; Beppu M
    J Biol Chem; 1994 Jul; 269(30):19394-8. PubMed ID: 7518456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opsonic potential of C3b-anti-band 3 complexes when generated on senescent and oxidatively stressed red cells or in fluid phase.
    Lutz HU; Stammler P; Kock D; Taylor RP
    Adv Exp Med Biol; 1991; 307():367-76. PubMed ID: 1805599
    [No Abstract]   [Full Text] [Related]  

  • 30. Aging of cell membrane molecules leads to appearance of an aging antigen and removal of senescent cells.
    Kay MM
    Gerontology; 1985; 31(4):215-35. PubMed ID: 3902578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Band 3, the predominant transmembrane polypeptide, undergoes proteolytic degradation as cells age.
    Kay MM
    Monogr Dev Biol; 1984; 17():245-53. PubMed ID: 6749147
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunocytochemical determination of membrane-bound IgG using physiologically aged and experimentally aged erythrocytes].
    Zimmerman N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(5):683-91. PubMed ID: 2481613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation of cellular life span.
    Kay M
    Ann N Y Acad Sci; 2005 Dec; 1057():85-111. PubMed ID: 16399889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.
    Kay MM; Marchalonis JJ; Hughes J; Watanabe K; Schluter SF
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5734-8. PubMed ID: 1696010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation.
    Kriebardis AG; Antonelou MH; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
    Transfusion; 2007 Jul; 47(7):1212-20. PubMed ID: 17581156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells.
    Galili U; Flechner I; Rachmilewitz EA
    Prog Clin Biol Res; 1985; 195():263-78. PubMed ID: 4059271
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoantibodies to band 3 during aging and disease and aging interventions.
    Kay MM; Wyant T; Goodman J
    Ann N Y Acad Sci; 1994 May; 719():419-47. PubMed ID: 7516632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Band 3 is a target protein of spectrin's E2/E3 activity: implication for sickle cell disease and normal red blood cell aging.
    Chang TL; Cubillos FF; Kakhniashvili DG; Goodman SR
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):171-7. PubMed ID: 15095787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Storage-related changes in erythrocyte band 3: not a case for the Diego blood group antigens.
    Bosman GJ; Klaarenbeek JM; Luten M; Bos HJ
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):195-200. PubMed ID: 16171555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Band 3 and its alterations in health and disease.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):117-38. PubMed ID: 15095783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.